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Abstract-The surface activity of triflupromazine, chlorpromazine, promazine, pro- 
methazine, and chlorpromazine sulfoxide has been determined at the air-solution 
interface by the drop-volume method to measure surface tension. Differences in the 
abilities of the various phenothiazines employed to affect surface pressure development 
seem correlated with their relative nonpolarities. Anionic buffer ingredients appear to 
have an affect on surface activity at pH 5.0. Increasing concentrations of phthalate, 
citrate, and succinate buffers tend to increase surface activity, while increasing the 
concentration of the acetate buffer has the opposite effect. Raising the pH greatly 
increases surface activity of chlorpromazine and its sulfoxide, but the low solubility 
of the un-ionized form of chlorpromazine prevents it from exhibiting surface activity 
unless a significant amount of protonated form is also present. The un-ionized form of 
chlorpromazine sulfoxide is more soluble than chlorpromazine, and it exhibits marked 
surface activity at high pH. 
ACCUMULATION at various biological membranes of chlorpromazine and other 
pharmacologically active phenothiazines has been demonstrated by a number of 
studies in vitro recently reviewed by Guth and Spirtes.r Guth et al2 have also shown 
that chlorpromazine acts at rat liver membranes in vivo as well as in vitro. In addition, 
studies with lipid monomolecular films to simulate the oriented structure of mem- 
branes have demonstrated that phenothiazine derivativesa- and other psychoactive 
drugs,5 in relatively low concentration, accumulate at the monolayer-solution 
interface. 
Whatever receptor surface or membrane may be involved in the action of the 
phenothiazines, it may be assumed that their widespread activity at membranes is 
dependent partially on their marked ability to “leave” an aqueous phase for a more 
nonpolar environment. The tendency of drugs to do this has often been correlated 
qualitatively with drug action by means of physical chemical measurements such as 
lipid solubility, p&, surface activity, and the ability to interact or complex with other 
molecules in solution. Measuring the adsorption of drugs at the air-solution interface 
offers many advantages for studying their escaping tendency from aqueous solution. 
Surface-tension measurements are extremely sensitive to factors which influence the 
properties of molecules in solution;6 and, since no chemically specific receptors are 
present, factors governing surface activity will be dependent on the relationship 
between solvent and drug. Thus, although the air-solution interface does not approach 
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a true receptor surface, its simplicity (air) and the sensitivity of surface-tension 
measurements make it a valuable tool, 
Two studies have been reported involving phenothiazines at the air-solution 
interface.79 s Both have demonstrated the surface activity of these compounds, but 
also have tended to oversimplify the picture. Villalonga et al.7 have measured the 
ability of four phenothiazines to lower the surface tension of an air-O-1 N HCI 
solution. They used the Gibbs equation to calculate the number of molecules adsorbed 
per unit area for various drug concentrations. Maximal adsorption at high concentra- 
tions was converted to area per molecule by taking reciprocals, and this was related 
to the geometry of molecular models. The differences in area obtained for prometha- 
zine (46 As) and promazine (66 A2) have been postulated as reasons for differing 
pharmacological action. 9 In general, however, areas obtained from such data do not 
approach the true dimensions of molecules at an interface. Rather, they are larger 
and subject to change by such factors as electrolyte concentration, pH, and mixed 
film formation. The region in which the area per molecule becomes independent of 
increasing concentration has been termed 10 the region of saturation adsorption. It is 
suggested that this commences somewhat before the critical micelle concentration due 
to a hydration layer around the polar group which prevents further reduction in area 
with increasing surface pressure. Ionic repulsion due to ionized polar groups may 
also contribute. Thus it is not surprising that these areas are subject to change by 
conditions in solution. 
Seeman and Bialys have measured the surface tension of psychoactive drug solutions 
at pH 7.0. Despite different chemical structures and p& values, all drugs exhibited the 
same saturation adsorption area of about 87 As. The constancy of the value, and the 
fact that it is larger than that reported at the lower pH7 where adsorption is less, is 
surprising. In addition, prelimina~ results in this laboratory3 at about the same pH 
indicate that concentrations required for surface activity are higher than those 
reported by Seeman and Bialy. This is apparent also from the results with sodium 
lauryl sulfate obtained by Roe and Brass.11 
In view of some of these questions and in order to probe more deeply into the 
problem, a study concerned with adsorption of phenothiazines at the air-solution 
interface was initiated. 
EXPERIMENTAL 
Materials 
Chlorpromazine HCl [2-chloro-lO-(3-dimethyIaminopropyl)phenothiazine] and its 
sulfoxide were generously supplied by Smith, Kline and French Laboratories, Phila- 
delphia, Pa. ; triflupromazine HCI ~2-trifluomethyl-1~(3-dimethylaminopropyl)- 
phenothiazine] was generously supplied by the Squibb Co., New Brunswick, N.J.; 
and promazine HCI [lo-(3-dimethylaminopropyl)phenoth.iazine] and promethazine 
HCl [lo-(2-dimethylamino-2methylethyl)phenothiazine] were generously supplied by 
Wyeth Laboratories, Philadelphia, Pa. These are designated in this study as CPZ, 
CPZ-0, TPZ, PZ, and PMZ, respectively. All were recrystallized from isopropyl 
alcohol with the exception of CPZ-0. All buffer ingredients and inorganic compounds 
were of reagent grade, and the water used was prepared by double distillation from 
alkaline permanganate solution. 
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Surface-tension measurments 
The drop-volume method12 was used for all surface-tension measurements. All 
drop volumes were independent of time, and thus the values of surface tension are 
equilibrium values. Preliminary studies showed no significant difference with the 
Wilhelmy plate method used previously,3 but the drop-volume method allowed for 
smaller solution volumes and less contact with the environment. This helped to 
eliminate possible drug decomposition. All studies were conducted at 25” & 0.1”. 
The drop volume apparatus* was essentially the same as that previously described13 
except for an inlet tube which allowed nitrogen to be introduced when necessary. 
The syringe tip was made of stainless steel and had a radius of 0.2967 cm. Details for 
calculating surface tension and for the experimental procedure have been described 
earlier.13 Since pH was maintained constant in all studies and excess counter-ions 
were present, the appropriate form of the Gibbs equationI was used to calculate 
the number of molecules adsorbed per unit area and, hence, the area per molecule. 
Measurements of surface pressure (surface tension of solvent minus surface tension 
of solution) were made under a variety of conditions. Studies were first conducted at 
pH 2-O where all the drugs are in the hydrochloride salt form. A 0.01 M HCl, 0.09 M 
NaCl solution was used as the solvent. Next, the possible effect that anionic buffer 
components might exert on surface activity, and the possible interfacial interaction of 
drug and buffer were considered. For this purpose surface pressures were measured 
in phthalate, citrate, succinate, and acetate buffers-all at pH 5-O and ionic strength 
0.1. Sodium chloride was used to adjust ionic strength in all cases. In order to observe 
the effect of the un-ionized species, measurements were made with CPZ at pH 7.2 in 
Tris and phosphate buffers (0.01 M); at pH 9.0 in a Tris buffer (0.01 M); and at 
pH 10.6, 11.4, and 12-O in NaOH solutions. CPZ-0 at pH 12.0 was also considered. 
All the drugs used in this study have reported pKa. values of 9-O or greater.159 16 
Studies at pH 2.0 
RESULTS 
Curves depicting the surface pressure change with the logarithm of molar concentra- 
tion at pH 2.0 are given in Fig. 1. A comparison of initial surface pressure changes 
indicates that TPZ is much more surface active than the other compounds. At the 
other extreme, little surface activity is observed for CPZ-0, although significant 
surface pressure development commences at concentrations approaching 0~1 M. 
CPZ, PZ, and PMZ begin to develop surface pressure in the same region of concen- 
tration, but subsequent changes are greater for CPZ. Values of area per molecule 
in square Angstroms at saturation adsorption are 66.3, 69.5, 65.5, and 77.0 for 
CPZ, TPZ, PZ, and PMZ respectively. The values for PZ agree quite well with those 
of Villalonga et al.;7 however, those for promethazine are quite different. Since one 
would expect less adsorption, and hence a higher area per molecule for a branch-chain 
isomer, the increase in area observed for promethazine in this study seems reasonable. 
The efect of buffers at pH 50 
Surface-pressure measurements for CPZ in the various buffer solutions at pH 5.0 
are given in Fig. 2 along with the curves obtained at pH 2.0 and 7.2. It is interesting 
* Frater Instrument Co., Corona, N.Y. 
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log molar concentration 
Pro. 1. Surface pressure (v) vs. log molar concentration of various drugs at pH 2.0, ionic strength 
@l-and 25”. Key: TPZ (0); CPZ (U); PZ to>; PMZ (e); CPZO (A). 
ll 
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FIG. 2. Surface pressure (r) vs. log molar concentration of CPZ, ionic strength 0.1, 25”, and in 
various buffers. Key: pH 50,0,073 M phthalate (0); pH 5.0, 0.025 M citrate (a); pH 50,0-10 M 
succinate (a); pH 5O, O-lO M acetate (Of; pH 7*&O-01 M Tris (I); pH 7.2,0*01 M phosphate (A). 
Dotted line depicts data for CPZ at pH 2-O. 
to note the increase in surface activity, as compared to pH 2.0, due to the phthalate, 
citrate, and succinate buffers and the decrease due to the acetate buffer. The same 
effects were noted for all drugs, the extent of change being greatest for TPZ, the most 
surface-active drug, and least for PMZ, the least surface-active drug. The buffer 
solutions alone exhibited no measurable surface activity. Dilution of each buffer with 
readjustment to an ionic strength of O-1 in NaCl, influences surface activity. Significant 
decreases in surface pressure were noted by diluting the phthalate, citrate, and succinate 
buffers, while increases in surface pressure were noted when the acetate was diluted. 
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FIG. 3. Surface pressure (T) vs. log molar concentration of TPZ in various concentrations of phthalate 
buffer at pH 5.0, ionic strength 0.1 and 25”. Key: O-073 M (0); 0.036 M (m); 0.015 M (ci); 
0.007 M (0). 
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PIG. 4. Surface pressure (n) vs. log molar concentration of TPZ in various concentrations of acetate 
buffer at pH 5.0, ionic strength O-1 and 25”. Key: 0.025 M (0); O-05 M (H); 0.10 M (CI). 
BP.-2R 
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The phthalate and citrate buffers seem to have a greater effect upon dilution than 
have the succinate and acetate buffers. Figures 3 and 4 indicate the effect of phthalate 
and acetate, respectively, on TPZ, the drug showing the greatest change upon dilution. 
The effect of the m-ionized species 
In Fig. 2 the surface activity of CPZ at pH 7.2 in Tris and phosphate buffers is 
depicted. It may be noted that the concentration range required for surface pressure 
development is much lower than at pH 2.0, and that the change in surface pressure 
with concentration is greater. This is reflected in a saturation adsorption area of 
51 AZ and 55 A2 in phosphate and Tris buffers respectively. These differ from the value 
of about 87 A2 given by Seeman and Bialys under similar conditions; however, the 
lower values seem more consistent with respect to studies at pH 2.0. The slight 
difference in data obtained for Tris and phosphate buffers appears to reflect a buffer 
effect similar to that seen at pH 5.0. It is interesting to note that CPZ in phthalate 
buffer, although seemingly completely ionized, exhibits surface pressures at lower 
concentrations than at pH 7.2. 
Since the degree of ionization for CPZ and, consequently, its solubility, are reduced 
markedly at pH values of 9.0 and higher, the unusual behavior observed in this pH 
region might be expected. For example, if the solution was prepared with the free 
base of CPZ, rather than the hydrochloride salt, no surface activity was noted up to 
the solubility Iimit (6 x 10-s M at pH 9.0 and 2.4 x 10-s M at pH 12.0). However, 
if the hydrochloride form was used, higher solubilities were noted (3 x 10-s M at 
pH 9.0). Surface pressures up to 4 dynes/cm were noted in this case, but only at the 
supersaturated levels. Lack of wetting along the sides of the glass container at these 
higher concentrations was also observed, probably owing to adsorption on the 
glass. It appears that an oil is produced when the hydrochloride is converted to the 
free base in situ, and that this oil is more water soluble. CPZ-0, which is more soluble 
than CPZ in the free base form, developed surface pressures of 4.5, 12.6, and 15.9 
dynes/cm for concentrations of 1 x lo-4 M, 4 x 10-J M, and 8 x 10~-1 M respec- 
tively. No adsorption on the glass containers was noted. 
DISCUSSION 
It is apparent from these studies that the phenothiazine derivatives considered 
have a strong tendency to leave an aqueous environment for one which is more non- 
polar. This is most striking when one compares surface properties of the pheno- 
thiazines with some of the local anesthetics studied by Skou.17 For instance, the 
concentration required to produce a 5 dyne/cm surface pressure at pH 3.5 for 
Nupercaine, the most active molecule studied, is about 6 x 10-a M; while at pH 
2.0, 8 x lo-4 M CPZ and 1 x 10-J M TPZ have the same effect. Even at pH 11.0 
completely un-ionized procaine has less surface activity than the un-ionized form of 
CPZ-0. 
By comparing the results of studies at pH 2.0, one can observe the marked effect 
substitution on the phenothiazine ring has on this “escaping tendency”. If the pheno- 
thiazine ring is considered the nonpolar portion of the molecme, one would expect 
such a critical dependence on different substituent groups. For instance, the addition 
of one -CH2- group to the alkyl chain of a surface-active agent reduces the con- 
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centration necessary to obtain the same surface pressure by about one third.18 The 
contribution of the more nonpolar -CF3- group, as in TPZ, would be expected to 
be greater, as seen in this study. The constancy of the saturation adsorption areas 
for TPZ, CPZ, and PZ at pH 2.0, as compared to a greater value for PMZ, would 
be expected also if the 3-dimethylaminopropyl moiety is considered the polar portion 
of TPZ, CPZ, and PZ, since Vader 10 has shown that the polar group is primarily 
responsible for these areas. Thus we see that substitution on different parts of these 
molecules appears to have significant yet different effects on their surface activity. 
Changes in the nonpolar group influence the concentration required for surface 
activity, while changes in the polar portion influence the maximal amount of ad- 
sorption. The former effect may be considered analogous to drug affinity as discussed 
by Ari&ns and Simonis, l9 while the latter may be considered analogous to the intrinsic 
activity of drugs. 
The marked effect of buffer ingredients is difficult to ascertain quantitatively because 
it was impossible to obtain the same concentration of each buffer species and still 
maintain pH and ionic strength constant. However, these results are interesting 
since they indicate the sensitivity of the adsorption process to environmental factors 
normally not considered. For instance, the fact that a solution is buffered to pH 5-O 
in bulk solution does not mean that the surface pH is 5.0. The surface concentration 
of the buffer ingredients may be greatly altered, owing to selective adsorption of one 
species over another, electrical repulsion and attraction of ions, and interaction of 
drug and buffer anions. Some evidence for interaction was noted by the observation 
that the solubility of the drugs is much less in the presence of the phthalate buffer 
than at pH 2.0. For example TPZ has a solubility of 7 x 1O-4 M in 0.07 M buffer, 
while that of PZ is about 3.5 x IO-3 M. Dilution of the buffer to 0.015 M gives a 
solubility of 2.4 x 10M3 M for TPZ and more than 1 x 10-l M for PZ. This latter 
result correlates well with the fact that the diluted buffer had practically no effect on 
PZ surface activity when compared to the effect at pH 2.0. Although it was impossible 
to isolate and identify a pure compound, an oil was produced, indicating some type of 
bulk interaction. Phase solubility analysis indicated that two species may be present, 
possibly the mono- and di-substituted phthalates. Unfortunately, the solubility 
of the drugs in the presence of the other buffers is quite high, and, in addition, spectral 
methods indicate no interactions. However, this does not preclude the possibility 
of surface complexation which could occur at these lower concentrations. The reverse 
effect of the acetate buffer is interesting and may be related to the influence of acetate 
ion on the structure of water .20 Studies concerned with possible surface complexation 
and factors influencing water structure are now underway. 
Whatever the mechanism of buffer effect may be, it is clear that any study comparing 
the action of these drugs in vitro must consider the influence of buffers and other 
species in solution. It is quite possible that these results may be of some importance 
in understanding the pharmacological action of these drugs. The ability to interact 
so readily with anionic species to form ion-pairs could play a role in the transport to 
and accumulation at membranes and other receptor surfaces. It is also apparent 
from these studies that differences between ionized and un-ionized phenothiazine 
molecules have little meaning if the ionized species combines with other molecules 
SO readily, and if the un-ionized species is no insoluble that significant concentrations 
are not attainable. 
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